Comprehensive Evaluation of GLP1 Receptor Agonists in Modulating Inflammatory Pathways and Gut Microbiota
DOI:
https://doi.org/10.53469/wjimt.2024.07(06).23Keywords:
GLP-1 Receptor Agonists, Inflammatory Cytokines, Gut Microbiota Modulation, Multi-Omics Analysis, Anti-Inflammatory TherapyAbstract
This study provides a detailed examination of the anti-inflammatory effects of GLP-1 receptor agonists (GLP-1RAs), employing an integrative approach that combines multi-omics analysis with in vivo and in vitro experiments. The results showed a significant decrease in pro-inflammatory cytokines (−42%±3.5%, p<0.001) alongside a notable increase in anti-inflammatory markers (+38%±4.2%, p<0.001). Additionally, the intervention induced substantial restructuring of the gut microbiota, characterized by a 2.8-fold enrichment of Faecalibacterium prausnitzii (p<0.01) and a 2.1-fold increase in Roseburia spp. (p<0.05), together with an increase in short-chain fatty acids level, especially butyrate (+35%, p<0.01). These changes were closely related to improved cytokine regulation and enhanced metabolic activity. Comparative analyses further showed that GLP-1RAs exhibit better efficacy in reducing inflammatory markers relative to NSAIDs, as evidenced by lower cytokine levels and inflammation scores across both animal models and cell culture systems (p<0.05). Transcriptomic profiling identified 154 differentially expressed genes, with the upregulation of key anti-inflammatory pathways and the downregulation of pro-inflammatory mediators. The findings highlight the potential of GLP-1RAs as a targeted therapy for systemic inflammation, leveraging their effects on cytokine modulation, gut microbiota composition and metabolic pathways. Future studies should focus on optimizing GLP-1RA-based interventions by exploring their long-term effects and potential synergies with microbiota-directed therapies for chronic inflammatory conditions.
References
Dama, A., Shpati, K., Daliu, P., Dumur, S., Gorica, E., & Santini, A. (2024). Targeting metabolic diseases: the role of nutraceuticals in modulating oxidative stress and inflammation. Nutrients, 16(4), 507.
Wang, Y., Wen, Y., Wu, X., Wang, L., & Cai, H. (2024). Modulation of Gut Microbiota and Glucose Homeostasis through High-Fiber Dietary Intervention in Type 2 Diabetes Management.
Alharbi, S. H. (2024). Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications. Therapeutic Advances in Endocrinology and Metabolism, 15, 20420188231222367.
Qiao, J. B., Fan, Q. Q., Xing, L., Cui, P. F., He, Y. J., Zhu, J. C., ... & Jiang, H. L. (2018). Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis. Journal of Controlled Release, 283, 113-125.
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013). Macrophage biology in development, homeostasis and disease. Nature, 496(7446), 445-455.
Qu, G., Hou, S., Qu, D., Tian, C., Zhu, J., Xue, L., ... & Zhang, C. (2019). Self-assembled micelles based on N-octyl-N’-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel. Carbohydrate polymers, 207, 428-439.
Madsen, M. S. A., Holm, J. B., Pallejà, A., Wismann, P., Fabricius, K., Rigbolt, K., ... & Hansen, H. H. (2019). Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice. Scientific reports, 9(1), 15582.
Zhu, J., Xie, R., Gao, R., Zhao, Y., Yodsanit, N., Zhu, M., ... & Gong, S. (2024). Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections. Nature Nanotechnology, 1-12.
Belli, M., Barone, L., Bellia, A., Sergi, D., Lecis, D., Prandi, F. R., ... & Barillà, F. (2022). Treatment of HFpEF beyond the SGLT2-is: does the addition of GLP-1 RA improve cardiometabolic risk and outcomes in diabetic patients?. International Journal of Molecular Sciences, 23(23), 14598.
Yodsanit, N., Shirasu, T., Huang, Y., Yin, L., Islam, Z. H., Gregg, A. C., ... & Wang, B. (2023). Targeted PERK inhibition with biomimetic nanoclusters confers preventative and interventional benefits to elastase-induced abdominal aortic aneurysms. Bioactive materials, 26, 52-63.
Brusini, R., Varna, M., & Couvreur, P. (2020). Advanced nanomedicines for the treatment of inflammatory diseases. Advanced drug delivery reviews, 157, 161-178.
Lee, I. K., Xie, R., Luz-Madrigal, A., Min, S., Zhu, J., Jin, J., ... & Ma, Z. (2023). Micromolded honeycomb scaffold design to support the generation of a bilayered RPE and photoreceptor cell construct. Bioactive Materials, 30, 142-153.
Wang, Y., Shen, M., Wang, L., Wen, Y., & Cai, H. (2024). Comparative Modulation of Immune Responses and Inflammation by n-6 and n-3 Polyunsaturated Fatty Acids in Oxylipin-Mediated Pathways.
Wang, Y., Wen, Y., Wu, X., & Cai, H. (2024). Application of Ultrasonic Treatment to Enhance Antioxidant Activity in Leafy Vegetables. International Journal of Advance in Applied Science Research, 3, 49-58.
Xu, K., Mo, X., Xu, X., & Wu, H. (2022). Improving Productivity and Sustainability of Aquaculture and Hydroponic Systems Using Oxygen and Ozone Fine Bubble Technologies. Innovations in Applied Engineering and Technology, 1-8.
Yang, J., Chen, T., Qin, F., Lam, M. S., & Landay, J. A. (2022, April). Hybridtrak: Adding full-body tracking to vr using an off-the-shelf webcam. In Proceedings of the 2022 CHI Conference on Human Factors in Computing Systems (pp. 1-13).
Zhu, J., Xu, T., Liu, M., & Chen, C. (2024). Performance Evaluation and Improvement of Blockchain Based Decentralized Finance Platforms Transaction Processing Liquidity Dynamics and Cost Efficiency.
Zhu, J., Xu, T., Zhang, Y., & Fan, Z. (2024). Scalable Edge Computing Framework for Real-Time Data Processing in Fintech Applications. International Journal of Advance in Applied Science Research, 3, 85-92.
Lian J. Research on Data Quality Analysis Based on Data Mining. Academic Journal of Science and Technology. 2024 Oct 10;12(3):16-9.
Liu, Z., Costa, C., & Wu, Y. (2024). Data-Driven Optimization of Production Efficiency and Resilience in Global Supply Chains. Journal of Theory and Practice of Engineering Science, 4(08), 23-33.
Liu, Z., Costa, C., & Wu, Y. (2024). Quantitative Assessment of Sustainable Supply Chain Practices Using Life Cycle and Economic Impact Analysis.
Liu, Z., Costa, C., & Wu, Y. (2024). Leveraging Data-Driven Insights to Enhance Supplier Performance and Supply Chain Resilience.
Masarova, L., Verstovsek, S., Liu, T., Rao, S., Sajeev, G., Fillbrunn, M., ... & Signorovitch, J. (2024). Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM. Future Oncology, 1-12.
An, L., Song, C., Zhang, Q., & Wei, X. (2024). Methods for assessing spillover effects between concurrent green initiatives. MethodsX, 12, 102672.
Shih, H. C., Wei, X., An, L., Weeks, J., & Stow, D. (2024). Urban and Rural BMI Trajectories in Southeastern Ghana: A Space-Time Modeling Perspective on Spatial Autocorrelation. International Journal of Geospatial and Environmental Research, 11(1), 3.
Wei, X., Bohnett, E., & An, L. Methodological Approaches to Assessing the Impact of Weather and Climate Patterns on Perceptions of Global Warming. Available at SSRN 4988579.
Ding, Y., Pedersen, S. S., Wang, H., Xiang, B., Wang, Y., Yang, Z., ... & Ball, Z. T. (2024). Selective Macrocyclization of Unprotected Peptides with an Ex Situ Gaseous Linchpin Reagent. Angewandte Chemie International Edition, e202405344.
Wei, X., Bohnett, E., & An, L. (2024). Assessing US Public Perceptions of Global Warming Using Social Survey and Climate Data. MethodsX, 103081.
Ayan, E., DeMirci, H., Serdar, M. A., Palermo, F., & Baykal, A. T. (2023). Bridging the gap between gut microbiota and Alzheimer’s disease: a metaproteomic approach for biomarker discovery in transgenic mice. International Journal of Molecular Sciences, 24(16), 12819.